Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Impact of Physical Exercise on Navigation Performance in Soldier

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02831036
Recruitment Status : Unknown
Verified July 2016 by Sheba Medical Center.
Recruitment status was:  Not yet recruiting
First Posted : July 13, 2016
Last Update Posted : July 13, 2016
Sponsor:
Collaborator:
Bar-Ilan University, Israel
Information provided by (Responsible Party):
Sheba Medical Center

Brief Summary:
20 healthy man, 10 in trial group and 10 in control group (randomly divided) will participate in the experiment on order to evaluate if improvement in physical fitness influences spatial learning in humans.

Condition or disease Intervention/treatment Phase
Spatial Learning Other: training program Other: VO2max test Other: spatial orientation test Not Applicable

Detailed Description:

subjects in both groups will perform 4 sets of VO2max test and spatial orientation test with a month between them (total 3 month).

in addition, subjects in trial group will follow a training program throughout the trial (running on treadmill 3 times a week), suited according to their result in the first VO2max test.

in each set VO2max test will be perform before spatial orientation test , in order to evaluated the subject`s aerobic fitness. the spatial orientation test is composed of 5 following days in which the subject has 3 attempts to arrive to a destination in xbox one controller using a virtual glasses (Oculus Rift DK2). each attempt duration is 2 min.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 20 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Official Title: The Impact of Physical Exercise on Navigation Performance in Soldier
Study Start Date : October 2016
Estimated Primary Completion Date : October 2017
Estimated Study Completion Date : April 2018

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: trial group
subjects in trial group will be following the experimental protocol (VO2max tests and spatial orientation tests) while performing a training program during the trial (3 months).
Other: training program
subjects in the trial group will follow a training program which includes 3 times a week running on a treadmill.

Other: VO2max test
each subject will perform 4 times VO2max test according to BRUCE protocol in order to evaluate his aerobic fitness.

Other: spatial orientation test
each subject will undergo 4 spatial orientation tests during the trial (month between 2 tests), each test is composed of 5 following days in which the subject will wear virtual reality glasses (Oculus Rift DK2) and attempt to arrive different destinations in a virtual maze tasks (using xbox one controller). each day will be given 3 attempts, the duration of each attempt is 2 min.

control group
following the experimental protocol (VO2max tests and spatial orientation tests)without performing additional exercise.
Other: VO2max test
each subject will perform 4 times VO2max test according to BRUCE protocol in order to evaluate his aerobic fitness.

Other: spatial orientation test
each subject will undergo 4 spatial orientation tests during the trial (month between 2 tests), each test is composed of 5 following days in which the subject will wear virtual reality glasses (Oculus Rift DK2) and attempt to arrive different destinations in a virtual maze tasks (using xbox one controller). each day will be given 3 attempts, the duration of each attempt is 2 min.




Primary Outcome Measures :
  1. spatial learning (composite) [ Time Frame: 20 experimental days for each participant ]
    each spatial orientation test length is 5 days. spatial learning is evaluated through time for completion and number of errors out of 3 attempts each day.


Secondary Outcome Measures :
  1. maximal aerobic capacity [ Time Frame: 4 experimental days for each participant ]
    VO2max tests along the trial are performed in order to evaluate the improvement or lack of improvement in both groups in correlation with their spatial learning.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 30 Years   (Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • civilian healthy man, aged 18-30
  • without any neurological or psychiatric disorder
  • not wearing eyeglasses

Exclusion Criteria:

  • athletes or trained man (for both groups)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02831036


Contacts
Layout table for location contacts
Contact: Haggai Schermann, M.D +972828771014 Haggai.Schermann@sheba.health.gov.il

Locations
Layout table for location information
Israel
Sheba medical center
Tel-Hashomer, Ramat- Gan, Israel
Sponsors and Collaborators
Sheba Medical Center
Bar-Ilan University, Israel
Investigators
Layout table for investigator information
Principal Investigator: Haggai Schermann, M.D Sheba Medical Center

Layout table for additonal information
Responsible Party: Sheba Medical Center
ClinicalTrials.gov Identifier: NCT02831036    
Other Study ID Numbers: SHEBA-16-3321-HS-CTIL
First Posted: July 13, 2016    Key Record Dates
Last Update Posted: July 13, 2016
Last Verified: July 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No